- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Niemann-Pick Disease, Type C1 in Finland
Total 1605 results
-
Endo PharmaceuticalsCompletedDupuytren's ContractureUnited States
-
Herbert Irving Comprehensive Cancer CenterUnknownBrain and Central Nervous System TumorsUnited States
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2France, United States, Mexico, United Kingdom, Spain, Canada, New Zealand, Thailand, Russian Federation, Brazil, Germany, Australia, Poland, Slovakia, Peru, Ukraine, South Africa, Costa Rica, Puerto Rico
-
PfizerCompletedHyperlipidemia | Hypercholesterolemia, FamilialUnited States, Canada, South Africa, Czech Republic, Italy, Finland, Netherlands, France
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Romania, Canada, Russian Federation, Czech Republic, Slovakia, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Puerto Rico
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Belgium, Hong Kong, United States, Germany, Portugal, Russian Federation, France, Canada, Finland, Austria, New Zealand, Spain, Poland, Thailand, Italy, Serbia, Korea, Republic of, Hungary, Mexico, Greece, Puerto Rico, Gu... and more
-
AstraZenecaCompletedUveal Melanoma | MetastaticUnited States, Czech Republic, Spain, United Kingdom, Germany, Canada, Israel, Netherlands, Belgium, France, Finland
-
Bristol-Myers SquibbCompletedDiabetes, Type 2United States, Canada, Mexico, Puerto Rico, Australia, Poland, Taiwan
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States
-
ImvaxActive, not recruitingGlioblastomaUnited States
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Thailand, United Kingdom, Malaysia, New Zealand, Taiwan, Turkey, Canada, Mexico, Israel, India, Argentina, Brazil, Russian Federation, Australia, Korea, Republic of, Italy, Philippines, Colombia, Poland, Chile, Finland and more
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, Italy, United Kingdom, Finland, Norway, Mexico, Austria, Denmark, Germany, Hungary, Greece, France, Spain
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | Long-term Effects Secondary to Cancer Therapy in ChildrenUnited States
-
Aarhus University HospitalGCP-unit at Aarhus University Hospital, Aarhus, DenmarkCompletedLymphoma, T-Cell, PeripheralNorway, Belgium, Finland, Denmark, Austria, Czechia, Portugal, Germany, Netherlands, Poland, Sweden
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and...Terminated
-
Actinogen MedicalICON Clinical ResearchCompletedDementia, Alzheimer TypeUnited States, Australia, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Slovakia, Turkey, Canada, Finland, France, Hungary, Korea, Republic of
-
European LeukemiaNetCompletedChronic Myeloid LeukemiaFrance, Denmark, Norway, Sweden, Czechia, Portugal, Germany, Netherlands, Finland, Greece
-
Numab Therapeutics AGRecruitingRenal Cell Carcinoma | Mesothelioma, Malignant | Adenocarcinoma of Lung | Triple Negative Breast Cancer | Endometrial Cancer | Fallopian Tube Carcinoma | Peritoneal Carcinoma | Leiomyosarcoma | Liposarcoma | Ovarian Carcinoma | Adenocarcinoma of the Stomach | Melanoma, Malignant | Adenocarcinoma - Gastroesophageal...United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Sweden, Finland, France, Norway
-
Eisai Inc.Thrombolysis In Myocardial Infarction (TIMI) Academic Research OrganizationCompletedObesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular RiskUnited States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
-
Novo Nordisk A/SRecruitingDiabetes, Type 2United States, India, Spain, Poland, South Africa, Bulgaria, Germany, Japan, Puerto Rico
-
PhenomixTerminatedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, India
-
Novo Nordisk A/SRecruitingType 2 Diabetes MellitusKorea, Republic of, United States, Hungary, Serbia, Spain, China, Australia, Finland, United Kingdom, Italy, Denmark, Canada, Taiwan, Poland, Germany, Sweden, South Africa, India, Argentina, Brazil, Bulgaria, Japan, Mexico, Turkey, Greece, Colomb... and more
-
Aadi Bioscience, Inc.RecruitingCancer | Endometrial Cancer | Tumor | Recurrent Endometrial Carcinoma | Endometrioid Endometrial Cancer | Endometrioid TumorUnited States
-
GlaxoSmithKlineCompletedHepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b VaccinesFinland, Australia, Spain, Italy, Canada, Czechia
-
Eli Lilly and CompanyCompletedObesity | Overweight | Type 2 DiabetesUnited States, Russian Federation, Taiwan, Argentina, Brazil, Japan, Puerto Rico, India
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); Genentech, Inc.; Oregon Health and Science University and other collaboratorsTerminatedCentral Nervous System B-Cell Non-Hodgkin LymphomaUnited States
-
SanofiCompletedEndometrial Neoplasms | Endometrial CancerUnited States, Belgium
-
Imugene LimitedRecruitingNon-Hodgkin Lymphoma | B-cell Acute Lymphoblastic LeukemiaUnited States
-
Bristol-Myers SquibbTerminatedLeukemia, Myeloid, ChronicSweden, United Kingdom, Russian Federation, France, Germany, Belgium, Portugal, Finland, Norway, Spain, Italy
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Japan, China, Puerto Rico, Romania, Brazil
-
AstraZenecaTerminatedType 2 DiabetesBrazil, France, Russian Federation, South Africa, Germany, Malaysia, Finland, Norway, Hong Kong, Canada, Hungary, Portugal, Taiwan, India, Philippines, Switzerland, Indonesia, Singapore
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
AstraZenecaCompletedType 2 DiabetesMexico, United States, Poland, Canada, Russian Federation, South Africa, France, Hungary, India, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesAustralia, United States, Canada, Mexico, Puerto Rico, Germany, Hungary, Ireland, Poland, Romania, Denmark, Czech Republic, India, Colombia, Finland, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Golfers Against CancerRecruitingOvarian CancerUnited States
-
TakedaCompletedDiabetes Mellitus, Type 2United States, Mexico, Guatemala
-
Oblato, Inc.Active, not recruitingRecurrent Malignant Glioma | Brain GlioblastomaUnited States
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, China, Italy, Japan, India, Poland, South Africa, Turkey, Greece, Puerto Rico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNordic CLL Study GroupActive, not recruitingChronic Lymphocytic Leukemia in Relapse | Chronic Lymphocytic Leukemia in RemissionNetherlands, Belgium, Denmark, Finland, Norway, Sweden
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusItaly, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, United States, Argentina, Brazil, Canada
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes MellitusUnited States, Germany, Mexico, Romania, Serbia, South Africa, Ukraine, Chile, Peru, Puerto Rico, Austria, Hungary, Slovakia, India, Czechia, Latvia, Argentina, United Kingdom
-
Bristol-Myers SquibbMedarexCompletedMelanomaUnited States, Spain, Austria, Italy, Sweden, Russian Federation, Ukraine, Finland, Norway, Poland
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2France, Poland, United Kingdom, United States, Spain, Colombia, India, Romania, South Africa, Ukraine, Australia, Canada, Greece, Sweden, New Zealand, Switzerland, Hong Kong